The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
p46, a Novel Natural Killer Cell–specific Surface Molecule That Mediates Cell Activation
Open accessAbstract
Limited information is available on the surface molecules that are involved in natural killer (NK) cell triggering. In this study, we selected the BAB281 monoclonal antibody (mAb) on the basis of its ability to trigger NK-mediated target cell lysis. BAB281 identified a novel NK cell–specific surface molecule of 46 kD (p46) that is expressed by all resting or activated NK cells. Importantly, unlike the NK cell antigens identified so far, the expression of p46 was strictly confined to NK cells. Upon mAb-mediated cross-linking, p46 molecules induced strong cell triggering leading to [Ca2+]i increases, lymphokine production, and cytolytic activity both in resting NK cells and NK cell clones. The p46-mediated induction of Ca2+ increases or triggering of cytolytic activity was downregulated by the simultaneous engagement of inhibitory receptors including p58, p70, and CD94/NKG2A. Both the unique cellular distribution and functional capability of p46 molecules suggest a possible role in the mechanisms of non-major histocompatibility complex–restricted cytolysis mediated by human NK cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Oligosaccharide ligands for NKR-P1 protein activate NK cells and cytotoxicity
Bezouška, K., Yuen, C.-T., O'Brien, J., Childs, R. A., Chai, W., Lawson, A. M., Drbal, K., Fišerová, A., Posíšil, M., & Feizi, T. (1994) · Nature · doi:10.1038/372150a0 · Cited by 250
RetractedBiology of Natural Killer Cells
Trinchieri, G. (1989) · Advances in Immunology · doi:10.1016/s0065-2776(08)60664-1 · Cited by 2,902
Herberman, R. B., Nunn, M. E., & Lavrin, D. H. (1975) · International Journal of Cancer · doi:10.1002/ijc.2910160204 · Cited by 1,355
Lanier, L. L., Le, A. M., Civin, C. I., Loken, M. R., & Phillips, J. H. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.12.4480 · Cited by 1,129
RECEPTORS FOR HLA CLASS-I MOLECULES IN HUMAN NATURAL KILLER CELLS
Moretta, A., Bottino, C., Vitale, M., Pende, D., Biassoni, R., Mingari, M. C., & Moretta, L. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.619 · Cited by 875
Self-citationColonna, M., & Samaridis, J. (1995) · Science · doi:10.1126/science.7716543 · Cited by 736
Wagtmann, N., Biassoni, R., Cantoni, C., Verdiani, S., Malnati, M. S., Vitale, M., Bottino, C., Moretta, L., Moretta, A., & Long, E. O. (1995) · Immunity · doi:10.1016/1074-7613(95)90025-x · Cited by 578
Self-citationMoretta, A., Vitale, M., Bottino, C., Orengo, A. M., Morelli, L., Augugliaro, R., Barbaresi, M., Ciccone, E., & Moretta, L. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.2.597 · Cited by 534
Self-citationMHC Class I Deficiency: Susceptibility to Natural Killer (NK) Cells and Impaired NK Activity
Liao, N.-S., Bix, M., Zijlstra, M., Jaenisch, R., & Raulet, D. (1991) · Science · doi:10.1126/science.1853205 · Cited by 490
Lazetic, S., Chang, C., Houchins, J. P., Lanier, L. L., & Phillips, J. H. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.11.4741 · Cited by 447
Moretta, A., Sivori, S., Vitale, M., Pende, D., Morelli, L., Augugliaro, R., Bottino, C., & Moretta, L. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.3.875 · Cited by 447
Self-citationNatural killer cells: definition of a cell type rather than a function
Lanier, L. L., Phillips, J. H., Hackett, J., Tutt, M., & Kumar, V (1987) · The Journal of Immunology · doi:10.4049/jimmunol.138.8.2745.a · Cited by 384
NKB1: a natural killer cell receptor involved in the recognition of polymorphic HLA-B molecules.
Litwin, V, Gumperz, J., Parham, P., Phillips, J. H., & Lanier, L. L. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.2.537 · Cited by 348
Biassoni, R., Cantoni, C., Falco, M., Verdiani, S., Bottino, C., Vitale, M., Conte, R., Poggi, A., Moretta, A., & Moretta, L. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.2.645 · Cited by 342
Self-citationMolecular cloning of NKB1. A natural killer cell receptor for HLA-B allotypes
D'Andrea, A., Chang, C., Franz-Bacon, K., McClanahan, T., Phillips, J. H., & Lanier, L. L. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.5.2306 · Cited by 310
Natural killer cells: definition of a cell type rather than a function.
Lanier, L. L., Phillips, J. H., Hackett, J., Tutt, M., & Kumar, V (1986) · The Journal of Immunology · doi:10.4049/jimmunol.137.9.2735 · Cited by 307
Phillips, J. H., Gumperz, J. E., Parham, P., & Lanier, L. L. (1995) · Science · doi:10.1126/science.7716542 · Cited by 305
Functional and biochemical analysis of CD16 antigen on natural killer cells and granulocytes.
Lanier, L. L., Ruitenberg, J. J., & Phillips, J. H. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.141.10.3478 · Cited by 299
Carretero, M., Cantoni, C., Bellón, T., Bottino, C., Biassoni, R., Rodríguez, A., Pérez‐Villar, J. J., Moretta, L., Moretta, A., & López‐Botet, M. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270230 · Cited by 281
Self-citationMoretta, A., Tambussi, G., Bottino, C., Tripodi, G., Merli, A., Ciccone, E., Pantaleo, G., & Moretta, L. (1990) · The Journal of Experimental Medicine · doi:10.1084/jem.171.3.695 · Cited by 250
Self-citationTriggering of Natural Killer Cells by the Costimulatory Molecule CD80 (B7-1)
Chambers, B. J., Salcedo, M., & Ljunggren, H.-G. (1996) · Immunity · doi:10.1016/s1074-7613(00)80257-5 · Cited by 227
Identification of a novel signal transduction surface molecule on human cytotoxic lymphocytes.
Valiante, N. M., & Trinchieri, G. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.4.1397 · Cited by 223
Mingari, M. C., Vitale, C., Cambiaggi, A., Schiavetti, F., Melioli, G., Ferrini, S., & Poggi, A. (1995) · International Immunology · doi:10.1093/intimm/7.4.697 · Cited by 219
Human Natural Killer Cells: Origin, Clonality, Specificity, and Receptors
Moretta, L., Ciccone, E., Mingari, M. C., Biassoni, R., & Moretta, A. (1993) · Advances in Immunology · doi:10.1016/s0065-2776(08)60513-1 · Cited by 214
Self-citationMoretta, A., Poggi, A., Pende, D., Tripodi, G., Orengo, A. M., Pella, N., Augugliaro, R., Bottino, C., Ciccone, E., & Moretta, L. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.6.1393 · Cited by 207
Self-citationThe Ly-49D Receptor Activates Murine Natural Killer Cells
Mason, L. H., Anderson, S. K., Yokoyama, W. M., Smith, H. R. C., Winkler-Pickett, R., & Ortaldo, J. R. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.184.6.2119 · Cited by 201
NKR-P1A is a target-specific receptor that activates natural killer cell cytotoxicity.
Ryan, J. C., Niemi, E. C., Nakamura, M. C., & Seaman, W. E. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.181.5.1911 · Cited by 126
Bléry, M., Delon, J., Trautmann, A., Cambiaggi, A., Olcese, L., Biassoni, R., Moretta, L., Chavrier, P., Moretta, A., Daëron, M., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.14.8989 · Cited by 124
Self-citationVitale, M., Sivori, S., Pende, D., Augugliaro, R., Donato, C. D., Amoroso, A., Malnati, M., Bottino, C., Moretta, L., & Moretta, A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.4.1453 · Cited by 114
Self-citationAzzoni, L., Kamoun, M., Salcedo, T. W., Kanakaraj, P., & Perussia, B. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.6.1745 · Cited by 106
Bolhuis, R. L. H., Roozemond, R. C., & van de Griend, R. J. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.11.3939 · Cited by 93
An unexpected petition for pardon
Kärre, K. (1992) · Current Biology · doi:10.1016/0960-9822(92)90179-e · Cited by 30
Cited by
Caligiuri, M. A. (2008) · Blood · doi:10.1182/blood-2007-09-077438 · Cited by 1,905
Activating Receptors and Coreceptors Involved in Human Natural Killer Cell-Mediated Cytolysis
Moretta, A., Bottino, C., Vitale, M., Pende, D., Cantoni, C., Mingari, M. C., Biassoni, R., & Moretta, L. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.197 · Cited by 1,778
Self-citationNK cells for cancer immunotherapy
Shimasaki, N., Jain, A., & Campana, D. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0052-1 · Cited by 1,222
Satoh-Takayama, N., Vosshenrich, C. A. J., Lesjean-Pottier, S., Sawa, S., Lochner, M., Rattis, F., Mention, J.-J., Thiam, K., Cerf-Bensussan, N., Mandelboim, O., et al. (2008) · Immunity · doi:10.1016/j.immuni.2008.11.001 · Cited by 1,095
Ferlazzo, G., Tsang, M. L., Moretta, L., Melioli, G., Steinman, R. M., & Münz, C. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011149 · Cited by 994
Self-citation
Metadata
- Authors
- Sivori, S., Vitale, M., Morelli, L., Sanseverino, L., Augugliaro, R., Bottino, C., Moretta, L., & Moretta, A.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 1997-10-06
- Volume
- 186
- Issue
- 7
- Pages
- 1129-1136
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2058522060
- Cited by
- 554
- References
- 32
- FWCI
- 7.22
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.